Barry Baylis, MD, graduated from the University of Calgary Medical School in 1983. He completed a post-graduate fellowship in Internal Medicine and in addition did a two-year fellowship in Endocrinology and Metabolism. He joined the faculty at the University of Calgary and the Foothills Medical Centre (FMC) in December 1989 as a founding member of the Division of General Internal Medicine. From 1989 onward he has contributed to undergraduate medical education, post-graduate medical education, and continuing medical education. He is also actively contributing to and has participated in clinical trials research at the FMC since 1990. His areas of research interest include: cardiovascular disease risk assessment and reduction, diabetes, diabetes in pregnancy, hypertension, lipid disorders, obesity, thrombophillia, and innovation in healthcare. As one of the founding leaders of W21C, he played a major role in the design of Unit 36 at FMC, and the creation of the W21C Living Laboratory. Dr. Baylis has been very active in fundraising for the initiative and has been heavily involved in its strategic direction as a member of its Executive Committee in his continued roll as a leader of the W21C. Dr. Baylis has an active interest in technology-based innovation, and has led work on fall prevention and location tracking in his time with W21C. He continues to mentor researchers through his participation in thesis committees for trainees associated with the W21C and serves on the W21C executive committee along with co-leads Ghali and Conly.
